Study Indicates Statin Use Lowers Heart Event Risk in Healthy Seniors

The STAREE trial, presented at ESC Congress 2026 and published in The New England Journal of Medicine, reported that atorvastatin treatment led to a 30% relative reduction in major cardiovascular events over six years in healthy adults over 70 with no prior cardiovascular disease. While serious adverse events were similar to placebo, the study did not show an increase in disability-free survival. This finding suggests a potential benefit for primary prevention in a specific older population, influencing discussions on statin use.